Development of an interphase fluorescent in situ hybridization (FISH) test to detect t(8;21) in AML patients

Leukemia
A HagemeijerN Sacchi

Abstract

The translocation (8;21) is a chromosome abnormality associated with acute myeloid leukemia (AML). As a consequence of the translocation the AML1 (CBFA2) gene in the 21q22 region is fused to the ETO(CDR,MTG8) gene in the 8q22 region, resulting in one transcriptionally active gene on the 8q- derivative chromosome. In this report we demonstrate the use of a highly specific dual-colour FISH method for the detection of t(8;21) on interphase cells. Genomic probes able to detect the chimeric AML1/ETO gene on the 8q- derivative chromosome were assayed on both normal and leukemic bone marrow and peripheral blood samples. Cut-off values were established by independent analysis of 15 bone marrow specimens negative for the translocation. The cut-off value of positive nuclei was determined to be 2% and the cut-off value for both positive nuclei and nuclei of uncertain classification, 4%. Persistence of cells above these cut-off values was interpreted as persistence of the mutated clone. A total of 36 samples at different disease stages were tested. Interphase cytogenetics detected the translocation at the onset and relapse in the BM or the PB of 14 AML patients with t(8;21). The technique appears to be an alternative tool to both conventio...Continue Reading

Citations

Jan 21, 2000·Hematological Oncology·S K MaL C Chan
Aug 10, 1999·Luminescence : the Journal of Biological and Chemical Luminescence·P E Stanley, L J Kricka
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·N C NausA Klein
Aug 5, 1999·Cancer Genetics and Cytogenetics·C J HarrisonE Macintyre
Dec 23, 2010·Future Oncology·Etienne De BraekeleerMarc De Braekeleer
Nov 3, 2006·Leukemia Research·Ronald Feitosa PinheiroMaria de Lourdes L F Chauffaille
Jul 6, 2004·Genes, Chromosomes & Cancer·Giorgina SpecchiaMariano Rocchi
Jan 31, 2003·Genes, Chromosomes & Cancer·Ulrike GamerdingerJochen Harbott
Aug 30, 2006·Cancer Genetics and Cytogenetics·Irina StasevichOlga Aleinikova
Aug 22, 2007·Ecological Applications : a Publication of the Ecological Society of America·Yoji Natori, Warren P Porter
Jan 14, 1999·Genes, Chromosomes & Cancer·S TaviauxM Lafage-Pochitaloff

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.